Abstract
Enoxaparin sodium is a heparin of low molecular weight with antithrombotic properties that acts by inhibiting factor Xa. We present a 59-year-old woman who developed heparin-related bullous hemorrhagic dermatosis, at sites distant from the injections, one month after starting treatment with enoxaparin.
MeSH terms
-
Enoxaparin / administration & dosage
-
Enoxaparin / adverse effects*
-
Female
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / adverse effects*
-
Hemorrhage / chemically induced*
-
Humans
-
Injections
-
Skin Diseases, Vesiculobullous / chemically induced*
-
Superior Vena Cava Syndrome / drug therapy
Substances
-
Enoxaparin
-
Fibrinolytic Agents